Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

#RemoteDetailing

- PMLiVE

Currencies hit Merck Serono sales but firm says it is ‘on course’

Overall groups sales down to €2.84bn for second quarter of 2013

Novartis building

Novartis says Afinitor fails liver cancer trial

Halts plans to file for approval in new indication

- PMLiVE

Elite Pharma names Actavis VP as CEO

Nasrat Hakim also has senior experience at Watson and Alpharma

- PMLiVE

FDA panel turns down Otsuka’s drug for rare kidney disease

Unable to recommend expanded use of tolvaptan

Roche's Perjeta pertuzumab

Roche’s breast cancer drug too expensive for NHS use

But pharma company says UK Government dithering on Perjeta patient access scheme

- PMLiVE

Sanofi vaccine against GI ‘superbug’ starts phase III

Aims to protect against Clostridium difficile

- PMLiVE

Roche loses Herceptin patents in India

Government says pharma company did not follow correct filing procedure

- PMLiVE

UN names special envoy for HIV/ AIDS in Africa

Speciosa Wandira-Kazibwe is former vice president of Uganda

Bayer symbol

Bayer to research cancer immunotherapies with Compugen

Will develop drugs that boost response of body’s immune system to tumours

- PMLiVE

Public disclosure under the spotlight

With the final approval of the EFPIA Disclosure Code at the end of June and the implementation of the US Sunshine Act starting in August, transparency requirements and public disclosure...

- PMLiVE

GSK loses patent on Tykerb in India

Cuts period of exclusivity by two years

Roche - Basel

Roche cuts cost of drug to prevent blindness in HIV patients

Will improve access to Valcyte in developing nations

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links